| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| RMD - ResMed Inc | HOLD | 0 @ USD 250.1 | USD 0 | The current share valuation price of RMD based on adjusted close was USD 250.1. The average price that RMD shares were previous bought at was USD 244.86. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in RMD has fallen by USD 28,302 compared to the previous valuation of ResMed Inc |
| LMAT - LeMaitre Vascular Inc | HOLD | 0 @ USD 87.79 | USD 0 | The current share valuation price of LMAT based on adjusted close was USD 87.79. The average price that LMAT shares were previous bought at was USD 88.5551. The current market price is -0.9% lower than average price they were purchased at. The value of the holding in LMAT has increased by USD 2,865 compared to the previous valuation of LeMaitre Vascular Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| MASI - Masimo Corporation | HOLD | 0 @ USD 144.5 | USD 0 | The current share valuation price of MASI based on adjusted close was USD 144.5. The average price that MASI shares were previous bought at was USD 154.973. The current market price is -6.8% lower than average price they were purchased at. The value of the holding in MASI has increased by USD 8,605 compared to the previous valuation of Masimo Corporation however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| MDT - Medtronic PLC | HOLD | 0 @ USD 92.66 | USD 0 | The current share valuation price of MDT based on adjusted close was USD 92.66. The average price that MDT shares were previous bought at was USD 89.4219. The current market price is 3.6% higher than average price they were purchased at. The value of the holding in MDT has increased by USD 81,955 compared to the previous valuation of Medtronic PLC however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| NVCR - Novocure Ltd | HOLD | 0 @ USD 11.27 | USD 0 | The current share valuation price of NVCR based on adjusted close was USD 11.27. The average price that NVCR shares were previous bought at was USD 17.8097. The current market price is -36.7% lower than average price they were purchased at. The value of the holding in NVCR has increased by USD 4,969 compared to the previous valuation of Novocure Ltd however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| NVST - Envista Holdings Corp | HOLD | 0 @ USD 20.05 | USD 0 | The current share valuation price of NVST based on adjusted close was USD 20.05. The average price that NVST shares were previous bought at was USD 19.1276. The current market price is 4.8% higher than average price they were purchased at. The value of the holding in NVST has increased by USD 14,062 compared to the previous valuation of Envista Holdings Corp however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| OFIX - Orthofix Medical Inc | HOLD | 0 @ USD 15.03 | USD 0 | The current share valuation price of OFIX based on adjusted close was USD 15.03. The average price that OFIX shares were previous bought at was USD 15.4031. The current market price is -2.4% lower than average price they were purchased at. The value of the holding in OFIX has increased by USD 360 compared to the previous valuation of Orthofix Medical Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| OMCL - Omnicell Inc | HOLD | 0 @ USD 36.81 | USD 0 | The current share valuation price of OMCL based on adjusted close was USD 36.81. The average price that OMCL shares were previous bought at was USD 34.6291. The current market price is 6.3% higher than average price they were purchased at. The value of the holding in OMCL has increased by USD 7,310 compared to the previous valuation of Omnicell Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| PEN - Pennant International Group plc | HOLD | 0 @ USD 270.55 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 270.55. The average price that PEN shares were previous bought at was USD 259.067. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in PEN has increased by USD 23,557 compared to the previous valuation of Pennant International Group plc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| PEN - PBF Energy Inc | HOLD | 0 @ USD 270.55 | USD 0 | The current share valuation price of PEN based on adjusted close was USD 270.55. The average price that PEN shares were previous bought at was USD 259.067. The current market price is 4.4% higher than average price they were purchased at. The value of the holding in PEN has increased by USD 23,557 compared to the previous valuation of PBF Energy Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| PODD - Insulet Corporation | HOLD | 0 @ USD 320.35 | USD 0 | The current share valuation price of PODD based on adjusted close was USD 320.35. The average price that PODD shares were previous bought at was USD 293.253. The current market price is 9.2% higher than average price they were purchased at. The value of the holding in PODD has increased by USD 5,200 compared to the previous valuation of Insulet Corporation however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| PRCT - Procept Biorobotics Corp | HOLD | 0 @ USD 30.9399 | USD 0 | The current share valuation price of PRCT based on adjusted close was USD 30.9399. The average price that PRCT shares were previous bought at was USD 59.3385. The current market price is -47.9% lower than average price they were purchased at. The value of the holding in PRCT has fallen by USD 7,555 compared to the previous valuation of Procept Biorobotics Corp |
| QDEL - Quidel Corporation | HOLD | 0 @ USD 19.73 | USD 0 | The current share valuation price of QDEL based on adjusted close was USD 19.73. The average price that QDEL shares were previous bought at was USD 34.337. The current market price is -42.5% lower than average price they were purchased at. The value of the holding in QDEL has fallen by USD 5,906 compared to the previous valuation of Quidel Corporation |
| LIVN - LivaNova PLC | HOLD | 0 @ USD 50.88 | USD 0 | The current share valuation price of LIVN based on adjusted close was USD 50.88. The average price that LIVN shares were previous bought at was USD 46.7757. The current market price is 8.8% higher than average price they were purchased at. The value of the holding in LIVN has increased by USD 3,222 compared to the previous valuation of LivaNova PLC however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| SIBN - Si-Bone Inc | HOLD | 0 @ USD 15.68 | USD 0 | The current share valuation price of SIBN based on adjusted close was USD 15.68. The average price that SIBN shares were previous bought at was USD 15.3583. The current market price is 2.1% higher than average price they were purchased at. The value of the holding in SIBN has fallen by USD 458 compared to the previous valuation of Si-Bone Inc |
| SRDX - SurModics Inc | HOLD | 0 @ USD 27.2703 | USD 0 | The current share valuation price of SRDX based on adjusted close was USD 27.2703. The average price that SRDX shares were previous bought at was USD 30.6595. The current market price is -11.1% lower than average price they were purchased at. The value of the holding in SRDX has increased by USD 936 compared to the previous valuation of SurModics Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| STE - STERIS plc | HOLD | 0 @ USD 264.01 | USD 0 | The current share valuation price of STE based on adjusted close was USD 264.01. The average price that STE shares were previous bought at was USD 229.731. The current market price is 14.9% higher than average price they were purchased at. The value of the holding in STE has increased by USD 3,287 compared to the previous valuation of STERIS plc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| SYK - Stryker Corporation | HOLD | 0 @ USD 355.02 | USD 0 | The current share valuation price of SYK based on adjusted close was USD 355.02. The average price that SYK shares were previous bought at was USD 374.89. The current market price is -5.3% lower than average price they were purchased at. The value of the holding in SYK has fallen by USD 48,324 compared to the previous valuation of Stryker Corporation |
| TFX - Teleflex Incorporated | HOLD | 0 @ USD 107.97 | USD 0 | The current share valuation price of TFX based on adjusted close was USD 107.97. The average price that TFX shares were previous bought at was USD 142.319. The current market price is -24.1% lower than average price they were purchased at. The value of the holding in TFX has fallen by USD 8,786 compared to the previous valuation of Teleflex Incorporated |
| TMCI - Treace Medical Concepts Inc | HOLD | 0 @ USD 3.56004 | USD 0 | The current share valuation price of TMCI based on adjusted close was USD 3.56004. The average price that TMCI shares were previous bought at was USD 7.60423. The current market price is -53.2% lower than average price they were purchased at. The value of the holding in TMCI has fallen by USD 5,449 compared to the previous valuation of Treace Medical Concepts Inc |
| TMDX - TransMedics Group Inc | HOLD | 0 @ USD 122.39 | USD 0 | The current share valuation price of TMDX based on adjusted close was USD 122.39. The average price that TMDX shares were previous bought at was USD 93.1357. The current market price is 31.4% higher than average price they were purchased at. The value of the holding in TMDX has increased by USD 15,266 compared to the previous valuation of TransMedics Group Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| TNDM - Tandem Diabetes Care Inc | HOLD | 0 @ USD 16.37 | USD 0 | The current share valuation price of TNDM based on adjusted close was USD 16.37. The average price that TNDM shares were previous bought at was USD 20.954. The current market price is -21.9% lower than average price they were purchased at. The value of the holding in TNDM has increased by USD 1,064 compared to the previous valuation of Tandem Diabetes Care Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| VREX - Varex Imaging Corp | HOLD | 0 @ USD 12.06 | USD 0 | The current share valuation price of VREX based on adjusted close was USD 12.06. The average price that VREX shares were previous bought at was USD 11.354. The current market price is 6.2% higher than average price they were purchased at. The value of the holding in VREX has increased by USD 498 compared to the previous valuation of Varex Imaging Corp however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| ZBH - Zimmer Biomet Holdings Inc | HOLD | 0 @ USD 88.73 | USD 0 | The current share valuation price of ZBH based on adjusted close was USD 88.73. The average price that ZBH shares were previous bought at was USD 102.421. The current market price is -13.4% lower than average price they were purchased at. The value of the holding in ZBH has increased by USD 6,327 compared to the previous valuation of Zimmer Biomet Holdings Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| EW - Edwards Lifesciences Corp | HOLD | 0 @ USD 84.08 | USD 0 | The current share valuation price of EW based on adjusted close was USD 84.08. The average price that EW shares were previous bought at was USD 73.2429. The current market price is 14.8% higher than average price they were purchased at. The value of the holding in EW has increased by USD 56,402 compared to the previous valuation of Edwards Lifesciences Corp however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| AORT - Artivion Inc | HOLD | 0 @ USD 44.9801 | USD 0 | The current share valuation price of AORT based on adjusted close was USD 44.9801. The average price that AORT shares were previous bought at was USD 34.7351. The current market price is 29.5% higher than average price they were purchased at. The value of the holding in AORT has increased by USD 635 compared to the previous valuation of Artivion Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| ATEC - Alphatec Holdings Inc | HOLD | 0 @ USD 20.24 | USD 0 | The current share valuation price of ATEC based on adjusted close was USD 20.24. The average price that ATEC shares were previous bought at was USD 13.2192. The current market price is 53.1% higher than average price they were purchased at. The value of the holding in ATEC has increased by USD 6,972 compared to the previous valuation of Alphatec Holdings Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| ATRC - AtriCure Inc | HOLD | 0 @ USD 31.99 | USD 0 | The current share valuation price of ATRC based on adjusted close was USD 31.99. The average price that ATRC shares were previous bought at was USD 35.4391. The current market price is -9.7% lower than average price they were purchased at. The value of the holding in ATRC has fallen by USD 414 compared to the previous valuation of AtriCure Inc |
| AXGN - Axogen Inc | HOLD | 0 @ USD 24 | USD 0 | The current share valuation price of AXGN based on adjusted close was USD 24. The average price that AXGN shares were previous bought at was USD 16.3377. The current market price is 46.9% higher than average price they were purchased at. The value of the holding in AXGN has increased by USD 2,581 compared to the previous valuation of Axogen Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| BAX - Baxter International Inc | HOLD | 0 @ USD 17.75 | USD 0 | The current share valuation price of BAX based on adjusted close was USD 17.75. The average price that BAX shares were previous bought at was USD 27.4613. The current market price is -35.4% lower than average price they were purchased at. The value of the holding in BAX has fallen by USD 17,831 compared to the previous valuation of Baxter International Inc |
| BDX - Becton Dickinson and Company | HOLD | 0 @ USD 181.64 | USD 0 | The current share valuation price of BDX based on adjusted close was USD 181.64. The average price that BDX shares were previous bought at was USD 201.977. The current market price is -10.1% lower than average price they were purchased at. The value of the holding in BDX has increased by USD 151,441 compared to the previous valuation of Becton Dickinson and Company however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| BSX - Boston Scientific Corporation | HOLD | 0 @ USD 100.91 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.91. The average price that BSX shares were previous bought at was USD 98.19. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 183,383 compared to the previous valuation of Boston Scientific Corporation however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| BSX - MULSTRXSSXIMETFP | HOLD | 0 @ USD 100.91 | USD 0 | The current share valuation price of BSX based on adjusted close was USD 100.91. The average price that BSX shares were previous bought at was USD 98.19. The current market price is 2.8% higher than average price they were purchased at. The value of the holding in BSX has increased by USD 183,383 compared to the previous valuation of MULSTRXSSXIMETFP however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| CNMD - CONMED Corporation | HOLD | 0 @ USD 43.95 | USD 0 | The current share valuation price of CNMD based on adjusted close was USD 43.95. The average price that CNMD shares were previous bought at was USD 56.641. The current market price is -22.4% lower than average price they were purchased at. The value of the holding in CNMD has fallen by USD 85 compared to the previous valuation of CONMED Corporation |
| DXCM - DexCom Inc | HOLD | 0 @ USD 54.84 | USD 0 | The current share valuation price of DXCM based on adjusted close was USD 54.84. The average price that DXCM shares were previous bought at was USD 75.1618. The current market price is -27.0% lower than average price they were purchased at. The value of the holding in DXCM has fallen by USD 8,723 compared to the previous valuation of DexCom Inc |
| ENOV - Enovis Corp | HOLD | 0 @ USD 30.26 | USD 0 | The current share valuation price of ENOV based on adjusted close was USD 30.26. The average price that ENOV shares were previous bought at was USD 36.4594. The current market price is -17.0% lower than average price they were purchased at. The value of the holding in ENOV has increased by USD 17,732 compared to the previous valuation of Enovis Corp however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| ABT - Abbott Laboratories | HOLD | 0 @ USD 125.89 | USD 0 | The current share valuation price of ABT based on adjusted close was USD 125.89. The average price that ABT shares were previous bought at was USD 128.636. The current market price is -2.1% lower than average price they were purchased at. The value of the holding in ABT has fallen by USD 113,748 compared to the previous valuation of Abbott Laboratories |
| GEHC - GE HealthCare Technologies Inc. | HOLD | 0 @ USD 73.48 | USD 0 | The current share valuation price of GEHC based on adjusted close was USD 73.48. The average price that GEHC shares were previous bought at was USD 74.9346. The current market price is -1.9% lower than average price they were purchased at. The value of the holding in GEHC has increased by USD 27,298 compared to the previous valuation of GE HealthCare Technologies Inc. however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| GKOS - Glaukos Corp | HOLD | 0 @ USD 88.35 | USD 0 | The current share valuation price of GKOS based on adjusted close was USD 88.35. The average price that GKOS shares were previous bought at was USD 106.937. The current market price is -17.4% lower than average price they were purchased at. The value of the holding in GKOS has increased by USD 35,673 compared to the previous valuation of Glaukos Corp however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| GMED - Globus Medical | HOLD | 0 @ USD 86.36 | USD 0 | The current share valuation price of GMED based on adjusted close was USD 86.36. The average price that GMED shares were previous bought at was USD 70.2905. The current market price is 22.9% higher than average price they were purchased at. The value of the holding in GMED has increased by USD 38,868 compared to the previous valuation of Globus Medical however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| HOLX - Hologic Inc | HOLD | 0 @ USD 74.3 | USD 0 | The current share valuation price of HOLX based on adjusted close was USD 74.3. The average price that HOLX shares were previous bought at was USD 67.0007. The current market price is 10.9% higher than average price they were purchased at. The value of the holding in HOLX has increased by USD 6,195 compared to the previous valuation of Hologic Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| IART - Integra LifeSciences Holdings | HOLD | 0 @ USD 12.1801 | USD 0 | The current share valuation price of IART based on adjusted close was USD 12.1801. The average price that IART shares were previous bought at was USD 17.8768. The current market price is -31.9% lower than average price they were purchased at. The value of the holding in IART has increased by USD 1,299 compared to the previous valuation of Integra LifeSciences Holdings however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| IDXX - IDEXX Laboratories Inc | HOLD | 0 @ USD 709.59 | USD 0 | The current share valuation price of IDXX based on adjusted close was USD 709.59. The average price that IDXX shares were previous bought at was USD 508.266. The current market price is 39.6% higher than average price they were purchased at. The value of the holding in IDXX has increased by USD 12,681 compared to the previous valuation of IDEXX Laboratories Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| INSP - Inspirit Energy Holdings Plc | HOLD | 0 @ USD 86.07 | USD 0 | The current share valuation price of INSP based on adjusted close was USD 86.07. The average price that INSP shares were previous bought at was USD 135.25. The current market price is -36.4% lower than average price they were purchased at. The value of the holding in INSP has increased by USD 16,012 compared to the previous valuation of Inspirit Energy Holdings Plc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| IRTC - iRhythm Technologies Inc | HOLD | 0 @ USD 176.3 | USD 0 | The current share valuation price of IRTC based on adjusted close was USD 176.3. The average price that IRTC shares were previous bought at was USD 129.4. The current market price is 36.2% higher than average price they were purchased at. The value of the holding in IRTC has increased by USD 7,616 compared to the previous valuation of iRhythm Technologies Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| ISRG - Intuitive Surgical Inc | HOLD | 0 @ USD 576.2 | USD 0 | The current share valuation price of ISRG based on adjusted close was USD 576.2. The average price that ISRG shares were previous bought at was USD 509.787. The current market price is 13.0% higher than average price they were purchased at. The value of the holding in ISRG has increased by USD 807,489 compared to the previous valuation of Intuitive Surgical Inc however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |
| ITGR - Integer Holdings Corp | HOLD | 0 @ USD 68.76 | USD 0 | The current share valuation price of ITGR based on adjusted close was USD 68.76. The average price that ITGR shares were previous bought at was USD 117.637. The current market price is -41.5% lower than average price they were purchased at. The value of the holding in ITGR has increased by USD 2,426 compared to the previous valuation of Integer Holdings Corp however if the holding was sold on 2025-11-10 this would crystalise an overall loss. |